Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000019402
JPRN-UMIN000019402
Completed
Phase 1

Comparison of the MRI sequence using different size of fidicual gold marker for intensity modulated radiotherapy for prostate cancer - Comparison of MRI sequence for prostate size and fidicual marker

Gifu Municipal Hospital0 sites30 target enrollmentOctober 19, 2015
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsprostate cancer

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
prostate cancer
Sponsor
Gifu Municipal Hospital
Enrollment
30
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 19, 2015
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Patient who reject our study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 2
The effect of ozone on the lumbar disc herniation using magnetic resonance imaging findingsumbar disc herniation.Thoracic, thoracolumbar, and lumbosacral intervertebral disc disorders
IRCT20170910036107N3Tabriz University of Medical Sciences50
Completed
Phase 4
Comparative study of routine MRI sequences for the diagnosis of cerebral venous sinus thrombosisCerebral venous sinus thrombosis
JPRN-UMIN000024324niversity of Miyazaki310
Completed
Phase 1
Comparison of MRI pulse sequences in defining outline of prostate and gold fiducial marker for CT/MRI fusion of IMRT for prostate cancerprostate cancer
JPRN-UMIN000019222Gifu Municipal Hospital30
Active, not recruiting
Phase 1
Comparison of 2 contrast agents for Magnetic Resonance Imaging in patients with liver cancerPatients with liver cirrhosis and diagnosis of hepatocellular carcinoma based on noninvasive HCC diagnostic (EASL) criteriaMedDRA version: 18.1Level: LLTClassification code 10024667Term: Liver cirrhosisSystem Organ Class: 100000004871MedDRA version: 18.1Level: LLTClassification code 10049010Term: Carcinoma hepatocellularSystem Organ Class: 100000004864Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Diagnosis [E01]
EUCTR2013-002409-75-DECharite30
Completed
Phase 2
Magnetic Resonance Angiography for Peripheral Arterial Disease (PAD)Peripheral Arterial Disease (PAD)
NCT00707876AMAG Pharmaceuticals, Inc.119